Company page

Palvella Therapeutics, Inc.

Palvella Therapeutics, Inc. is a public company traded under the ticker PVLA in the American market. The company has a market capitalization of approximately $1.98 billion. Palvella focuses on developing innovative therapies for patients with rare diseases.

PVLA:NASDAQUpdated August 14, 2026
Palvella Therapeutics, Inc. logo
Ticker
PVLA:NASDAQ
Asset type
Stock
Market cap
$2.25B
Sector
Health Technology
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD